Cymbiotika, a San Diego-based science-backed well
Author: Michael
FibroBiologics, Inc.
First-in-class neurodegeneration drug nears Phas
FDA designation accelerates development of a nov
Relation Therapeutics Limited said it has entered
Cognition Therapeutics announced publication of P
A new market analysis projects that the global cu
Stealth BioTherapeutics provided a commercial and
Engitix is betting that fixing the body’s dama
Company aims to extend human healthspan via a co